city New Delhi Usa India covid-19 Ventilators patient city New Delhi Usa India

Zydus Cadila signs licensing pact with Gilead for covid-19 drug remdesivir

Reading now: 604
www.livemint.com

NEW DELHI : Zydus Cadila on Friday announced that it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for the manufacturing and sale of the promising covid-19 drug remdesivir.This makes Zydus Cadila the fifth company in India and sixth in the world to sign licensing agreement for Gilead’s novel intravenous drug, which has received emergency use authorisation (EUA) in both the US, India and a few other countries for the treatment of covid-19.Last month, Gilead Sciences Inc signed non-exclusive voluntary licensing agreements with five generic pharmaceutical manufacturers – Cipla Ltd, Jubilant Life Sciences, Hetero Labs Ltd, Mylan and Ferozsons Laboratories – on a royalty-free basis.Of the five, Ferozsons Laboratories is.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA